Insufficient scRNA-seq data for expression of PRAMEF9 at single-cell level.
Insufficient scRNA-seq data for expression of PRAMEF9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 5% | 0.23 | 11 / 226 | 2% | 0.04 | 7 / 406 |
peripheral blood | 4% | 0.06 | 33 / 929 | 0% | 0 | 0 / 0 |
muscle | 3% | 0.07 | 25 / 803 | 0% | 0 | 0 / 0 |
pancreas | 3% | 0.04 | 9 / 328 | 0% | 0 | 0 / 178 |
uterus | 2% | 0.04 | 4 / 170 | 0% | 0 | 0 / 459 |
blood vessel | 2% | 0.05 | 30 / 1335 | 0% | 0 | 0 / 0 |
prostate | 2% | 0.05 | 5 / 245 | 0% | 0 | 0 / 502 |
ovary | 0% | 0 | 0 / 180 | 2% | 0.03 | 8 / 430 |
adipose | 2% | 0.03 | 20 / 1204 | 0% | 0 | 0 / 0 |
thymus | 2% | 0.02 | 10 / 653 | 0% | 0 | 0 / 605 |
skin | 1% | 0.02 | 16 / 1809 | 1% | 0.01 | 3 / 472 |
esophagus | 1% | 0.04 | 21 / 1445 | 0% | 0 | 0 / 183 |
intestine | 1% | 0.03 | 14 / 966 | 0% | 0 | 0 / 527 |
heart | 1% | 0.02 | 11 / 861 | 0% | 0 | 0 / 0 |
spleen | 1% | 0.05 | 3 / 241 | 0% | 0 | 0 / 0 |
brain | 1% | 0.03 | 25 / 2642 | 0% | 0 | 0 / 705 |
lung | 1% | 0.02 | 5 / 578 | 0% | 0 | 0 / 1155 |
stomach | 1% | 0.02 | 3 / 359 | 0% | 0 | 0 / 286 |
breast | 0% | 0.00 | 2 / 459 | 0% | 0 | 0 / 1118 |
adrenal gland | 0% | 0.00 | 1 / 258 | 0% | 0 | 0 / 230 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 1 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045596 | Biological process | negative regulation of cell differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0016567 | Biological process | protein ubiquitination |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0031462 | Cellular component | Cul2-RING ubiquitin ligase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
Gene name | PRAMEF9 |
Protein name | PRAME family member 9 |
Synonyms | |
Description | FUNCTION: Substrate-recognition component of a Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex, which mediates ubiquitination of target proteins, leading to their degradation . The CRL2(PRAMEF9) complex mediates ubiquitination and degradation of truncated MSRB1/SEPX1 selenoproteins produced by failed UGA/Sec decoding . . |
Accessions | A0A096LNW4 ENST00000633914 B7ZW04 P0DUQ2 ENST00000637423.1 ENST00000415919.3 A0A0G2JP20 A0A1B0GU46 ENST00000612758.3 |